Lazertinib is a an orally available third-generation, selective inhibitor of certain forms of the epidermal growth factor receptor (EGFR) .
For research use only. We do not sell to patients.
Name | Lazertinib mesylate |
---|---|
Iupac Chemical Name | N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide methanesulfonate |
Synonyms | lazertinib mesylate |
Molecular Formula | C30H34N8O3*CH4O3S |
Molecular Weight | 650.759 |
Smile | C=CC(NC1=CC(NC2=NC=CC(N3N=C(C4=CC=CC=C4)C(CN(C)C)=C3)=N2)=C(OC)C=C1N5CCOCC5)=O.CS(=O)(O)=O |
InChiKey | BXBUSQVSAAMGMR-UHFFFAOYSA-N |
InChi | InChI=1S/C30H34N8O3.CH4O3S/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21;1-5(2,3)4/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34);1H3,(H,2,3,4) |
CAS Number | 2247995-37-3 |
Related CAS | 2247995-37-3 ; 2867596-17-4 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |